# Balchem Corp (BCPC)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/balchem-corp/ JSON: https://steadybase.io/company/balchem-corp.json Checked Nov 10, 2026. Latest filing read: Oct 23, 2026.

## Company

- Legal name: BALCHEM CORP
- Ticker: BCPC (Nasdaq)
- SEC CIK: 0000009326
- Industry: Chemicals & Allied Products (SIC 2800)
- Headquarters: Montvale, NJ
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: balchem.com
- LinkedIn: https://www.linkedin.com/company/balchem-corporation
- Next earnings date: Jan 23, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $1.0B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/0000009326-26-000007-index.html
- Operating income: $209.3M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/0000009326-26-000007-index.html
- Net income: $154.8M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/0000009326-26-000007-index.html
- SG&A: $67.4M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/0000009326-26-000007-index.html
- Employees: 1,352 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- Shares outstanding: 31,777,324 as of Oct 15, 2026 (10-Q filed Oct 23, 2026). Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000035/0000009326-26-000035-index.html
- Auditor: Rsm Us LLP, New York, New York, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm

## Business

Balchem Corporation (“Balchem,” the “Company,” “we” or “us”), was incorporated in the State of Maryland in 1967. We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $1.0B | $209.3M | $154.8M | $67.4M |
| Dec 31, 2024 | $953.7M | $182.9M | $128.5M | $67.6M |
| Dec 31, 2023 | $922.4M | $159.2M | $108.5M | $53.4M |
| Dec 31, 2022 | $942.4M | $145.2M | $105.4M | $55.7M |
| Dec 31, 2021 | $799.0M | $127.5M | $96.1M | $41.7M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/balchem-corp.json

## Officers and directors

- Ted Harris, Chairman, President and CEO of Balchem. LinkedIn: https://www.linkedin.com/in/ted-harris-6bb5ab25b. Source: 8-K filed Oct 23, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000032/exhibit991-q32026.htm
- Theodore L. Harris, Chairman, President and Chief Executive Officer. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- C. Martin Bengtsson, Executive Vice President and Chief Financial Officer. LinkedIn: https://linkedin.com/in/martin-bengtsson-47a863. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- Carl Martin Bengtsson, EVP & Chief Financial Officer. Source: Form 4 filed Feb 13, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126005510/0001140361-26-005510-index.htm
- Ren Anthony Gonzalez, SVP and Chief R&D Officer. Source: Form 3 filed Sep 24, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126037570/0001140361-26-037570-index.htm
- Erin Leigh Gilson, Chief Accounting Officer. Source: Form 3 filed Apr 7, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126013681/0001140361-26-013681-index.htm
- George Graham, Senior Vice President and Chief R&D Officer. LinkedIn: https://linkedin.com/in/george-graham-exchange. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- Hatsuki Miyata, Executive Vice President, Chief Legal Officer and Secretary. LinkedIn: https://linkedin.com/in/hmiyata. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- Martin L. Reid, Senior Vice President and Chief Supply Chain Officer. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- William A. Backus, Vice President and Chief Accounting Officer. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- Martin Luther Reid, SVP Chief Supply Chain Officer. Source: Form 4 filed Feb 13, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126005542/0001140361-26-005542-index.htm
- Michael Brent Tignor, SVP & Chief HR Officer. Source: Form 4 filed Feb 13, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126005516/0001140361-26-005516-index.htm
- Frederic Boned, Senior Vice President and General Manager, Human Nutrition and Health. LinkedIn: https://linkedin.com/in/frederic-boned-8941ba10. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- Gunsteren Job Leonard van, SVP and GM, Specialty Products. Source: Form 4 filed Feb 13, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126005544/0001140361-26-005544-index.htm
- Daniel Knutson, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm
- David Fischer, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm
- Kathleen Fish, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm
- M. Brent Tignor, Named in proxy. LinkedIn: https://linkedin.com/in/brent-tignor-0b73966. Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm
- Matthew Wineinger, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm
- Monica Vicente, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm
- Olivier Rigaud, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm
- Theodore Harris, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm

## Recent 8-K events

- Oct 23, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000032/bcpc-20261023.htm
- Jul 31, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000026/bcpc-20260731.htm
- Jul 27, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000114036126029658/ef20078813_8k.htm
- Jun 22, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/9326/000114036126025971/ef20076533_8k.htm
- Apr 30, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000016/bcpc-20260430.htm
- Feb 20, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000004/bcpc-20260220.htm
- Feb 19, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000114036126006184/ef20065786_8k.htm
- Dec 10, 2025: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000114036125045137/ef20061036_8k.htm
- Oct 21, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932625000019/bcpc-20251021.htm
- Jul 31, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/9326/000000932625000012/bcpc-20250731.htm

## Insider trades (Form 4)

- Dec 4, 2025: Gunsteren Job Leonard van (SVP and GM, Specialty Products) sold 6,000 shares, about $919,708. Source: https://www.sec.gov/Archives/edgar/data/9326/000114036125044551/0001140361-25-044551-index.htm
- Dec 3, 2025: David B. Fischer (Director) sold 8,000 shares, about $1.2M. Source: https://www.sec.gov/Archives/edgar/data/9326/000114036125044554/0001140361-25-044554-index.htm
- Nov 11, 2025: Martin Luther Reid (SVP Chief Supply Chain Officer) sold 1,200 shares, about $185,328. Source: https://www.sec.gov/Archives/edgar/data/9326/000114036125041986/0001140361-25-041986-index.htm

## What management said

- "Balchem delivered another excellent quarter, with healthy growth across all three of our reporting segments and record consolidated quarterly net sales, net earnings, and adjusted EBITDA" Ted Harris, Chairman, President and CEO of Balchem (8-K filed Oct 23, 2026). Source: https://www.sec.gov/Archives/edgar/data/9326/000000932626000032/exhibit991-q32026.htm

## Latest filings

- 8-K filed Oct 23, 2026: https://www.sec.gov/Archives/edgar/data/9326/000000932626000032/bcpc-20261023.htm
- 10-K filed Feb 20, 2026: https://www.sec.gov/Archives/edgar/data/9326/000000932626000007/bcpc-20251231.htm
- 10-Q filed Oct 23, 2026: https://www.sec.gov/Archives/edgar/data/9326/000000932626000035/bcpc-20260930.htm
- DEF 14A filed Apr 27, 2026: https://www.sec.gov/Archives/edgar/data/9326/000114036126017099/ny20063370x1_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/